We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Labeling Draft Encourages Graphics for Pharmacology
FDA Labeling Draft Encourages Graphics for Pharmacology
March 6, 2009
The clinical pharmacology section of a drug label should generally contain positive and pertinent negative findings about the product and should avoid repeating information contained elsewhere on the label as much as possible, the FDA says in a draft guidance.